Cargando…
PGC1α overexpression preserves muscle mass and function in cisplatin‐induced cachexia
BACKGROUND: Chemotherapy induces a cachectic‐like phenotype, accompanied by skeletal muscle wasting, weakness and mitochondrial dysfunction. Peroxisome proliferator‐activated receptor‐gamma coactivator‐1 alpha (PGC1α), a regulator of mitochondrial biogenesis, is often reduced in cachectic skeletal m...
Autores principales: | Huot, Joshua R., Pin, Fabrizio, Chatterjee, Rohit, Bonetto, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530502/ https://www.ncbi.nlm.nih.gov/pubmed/35903870 http://dx.doi.org/10.1002/jcsm.13035 |
Ejemplares similares
-
HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia
por: Huot, Joshua R., et al.
Publicado: (2020) -
The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice
por: Pin, Fabrizio, et al.
Publicado: (2022) -
Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition
por: Pin, Fabrizio, et al.
Publicado: (2018) -
PGC-1α overexpression is not sufficient to mitigate cancer cachexia in either male or female mice
por: Morena da Silva, Francielly, et al.
Publicado: (2022) -
ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia
por: Huot, Joshua R., et al.
Publicado: (2020)